Literature DB >> 7420231

Chlorambucil treatment in minimal lesion nephrotic syndrome: a reappraisal of its gonadal toxicity.

L Callis, J Nieto, A Vila, J Rende.   

Abstract

Twenty-six preadolescent children ( 16 boys and 10 girls) with minimal lesion nephrotic syndrome, who were either unresponsive to or dependent on corticosteroid therapy, were treated exclusively with chlorambucil. Evaluation of chlorambucil toxicity on the reproductive system was based on penile and testicular size, serum testosterone values, and sperm count. Nine boys had azoospermia and one had oligospermia. The other six, who received a mean cumulative dose of 10.2 mg/kg of chlorambucil, had a normal sperm count. However, we consider that the total safe dose of chlorambucil should not exceed 8.2 mg/kg, equivalent to six weeks treatment at a daily dose of 0.2 mg/kg. In the ten girls, pubertal development was normal; axillary and pubic hair, breast development, age at onset of menarche, and length of the menstrual cycle were all normal; however, the possibility of abnormalities in ovarian functions cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7420231     DOI: 10.1016/s0022-3476(80)80035-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  13 in total

1.  High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet's disease.

Authors:  H H Tessler; T Jennings
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

2.  Evaluation of chlorambucil therapy in steroid-dependent and cyclophosphamide-resistant children with nephrosis.

Authors:  A Y Elzouki; O P Jaiswal
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

Review 3.  The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies.

Authors:  J Brodehl
Journal:  Eur J Pediatr       Date:  1991-04       Impact factor: 3.183

4.  The long-term outcome of childhood nephrotic syndrome in Germany: a cross-sectional study.

Authors:  Malik Aydin; Ingo Franke; Lisa Kurylowicz; Rainer Ganschow; Michael Lentze; Mark Born; Rebekka Hagemann
Journal:  Clin Exp Nephrol       Date:  2019-02-05       Impact factor: 2.801

5.  Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pädiatrische Nephrologie.

Authors: 
Journal:  Arch Dis Child       Date:  1987-11       Impact factor: 3.791

6.  Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. The French Society of Paediatric Nephrology.

Authors:  P Niaudet
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

7.  Alternative treatment to corticosteroids in steroid sensitive idiopathic nephrotic syndrome.

Authors:  T J Neuhaus; J Fay; M J Dillon; R S Trompeter; T M Barratt
Journal:  Arch Dis Child       Date:  1994-12       Impact factor: 3.791

8.  Twenty cases of sympathetic ophthalmia.

Authors:  T Jennings; H H Tessler
Journal:  Br J Ophthalmol       Date:  1989-02       Impact factor: 4.638

Review 9.  Clinical pharmacology and modification of autoimmunity and inflammation in rheumatoid disease.

Authors:  R Luqmani; C Gordon; P Bacon
Journal:  Drugs       Date:  1994-02       Impact factor: 9.546

Review 10.  Focal segmental glomerulosclerosis.

Authors:  I Ichikawa; A Fogo
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.